Contineum Therapeutics Ratios (2023-2025) | CTNM

Ratios Mar2023 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 5,243.48%84.60%
EBIT Margin 5,559.78%77.87%
EBITDA Margin 5,170.65%83.02%
Operating Margin 5,559.78%77.87%
Net Margin 5,243.48%83.14%
FCF Margin 5,756.52%81.29%
Efficiency
Assets Average 126.97M172.46M218.69M214.44M205.56M190.58M186.87M
Equity Average -71.78M70.94M213.87M204.15M191.42M178.08M175.93M
Invested Capital -67.94M-75.63M217.50M210.23M198.07M184.77M171.39M180.47M
Asset Utilization Ratio 0.39
Leverage & Solvency
Interest Coverage Ratio -55.60335.66
Equity Ratio -0.52-0.610.980.970.930.930.940.95
Times Interest Earned -55.60335.66
Valuation
Enterprise Value -125.19M-117.91M-218.65M-213.91M-204.76M-190.71M-175.48M-182.41M
Return Ratios
Return on Sales 52.43%0.83%0.46%0.38%
Return on Capital Employed 0.09%-0.23%-0.20%-0.25%
Return on Invested Capital -0.15%-0.54%-0.20%
Return on Assets 0.15%-0.18%-0.16%-0.20%-0.16%-0.13%-0.08%
Return on Equity -0.27%-0.44%-0.17%-0.21%-0.18%-0.14%-0.08%